Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yibing Shan

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Nature Communications|August 17, 2021
Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerizationChristopher Agnew, Pelin Ayaz, Risa Kashima, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2015
Allosteric activation of apicomplexan calcium-dependent protein kinasesJessica R Ingram, Kevin E Knockenhauer, Benedikt M Markus, et al.
Nature Communications|April 5, 2023
Structural mechanism of a drug-binding process involving a large conformational change of the protein targetPelin Ayaz, Agatha Lyczek, YiTing Paung, et al.
Science (New York, N.Y.)|October 16, 2010
Atomic-level characterization of the structural dynamics of proteinsDavid E Shaw, Paul Maragakis, Kresten Lindorff-Larsen, et al.
Cell|February 5, 2013
Conformational coupling across the plasma membrane in activation of the EGF receptorNicholas F Endres, Rahul Das, Adam W Smith, et al.
The Journal of Biological Chemistry|October 7, 2024
Experimental variables determine the outcome of RAS-RAS interactionsZhiwei Zhou, Tra Ly Nguyen, Xingxiao Li, et al.
Journal of Chemical Theory and Computation|December 4, 2015
Automated Event Detection and Activity Monitoring in Long Molecular Dynamics SimulationsWilly Wriggers, Kate A Stafford, Yibing Shan, et al.
Elife|September 26, 2014
How IGF-1 activates its receptorJennifer M Kavran, Jacqueline M McCabe, Patrick O Byrne, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Regulation of RAS oncogenicity by acetylationMoon Hee Yang, Seth Nickerson, Eric T Kim, et al.
Cell Reports|February 2, 2022
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancersMarcia R Campbell, Ana Ruiz-Saenz, Elliott Peterson, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Nature Communications|August 17, 2021
Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerizationChristopher Agnew, Pelin Ayaz, Risa Kashima, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2015
Allosteric activation of apicomplexan calcium-dependent protein kinasesJessica R Ingram, Kevin E Knockenhauer, Benedikt M Markus, et al.
Nature Communications|April 5, 2023
Structural mechanism of a drug-binding process involving a large conformational change of the protein targetPelin Ayaz, Agatha Lyczek, YiTing Paung, et al.
Science (New York, N.Y.)|October 16, 2010
Atomic-level characterization of the structural dynamics of proteinsDavid E Shaw, Paul Maragakis, Kresten Lindorff-Larsen, et al.
Cell|February 5, 2013
Conformational coupling across the plasma membrane in activation of the EGF receptorNicholas F Endres, Rahul Das, Adam W Smith, et al.
The Journal of Biological Chemistry|October 7, 2024
Experimental variables determine the outcome of RAS-RAS interactionsZhiwei Zhou, Tra Ly Nguyen, Xingxiao Li, et al.
Journal of Chemical Theory and Computation|December 4, 2015
Automated Event Detection and Activity Monitoring in Long Molecular Dynamics SimulationsWilly Wriggers, Kate A Stafford, Yibing Shan, et al.
Elife|September 26, 2014
How IGF-1 activates its receptorJennifer M Kavran, Jacqueline M McCabe, Patrick O Byrne, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Regulation of RAS oncogenicity by acetylationMoon Hee Yang, Seth Nickerson, Eric T Kim, et al.
Cell Reports|February 2, 2022
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancersMarcia R Campbell, Ana Ruiz-Saenz, Elliott Peterson, et al.
Pageof 4